医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mitsubishi Electric to Provide Funding and Supplies to Support Coronavirus (COVID-19) Relief Efforts in Japan

2020年05月13日 AM11:10
このエントリーをはてなブックマークに追加


 

TOKYO

Mitsubishi Electric Corporation (TOKYO:6503) announced today that it will support healthcare professionals in the fight against COVID-19 by donating approximately 100 million yen (about US$ 930,000) and providing medical institutions with essential items such as medical masks. The company is taking all possible steps to help contain the disease and resume normal socio-economic activities as soon as possible.

Donation of Approximately 100 Million Yen

Mitsubishi Electric will donate approximately 100 million yen to support healthcare professionals working on the frontline and children affected by the prolonged closure of schools. The funds will come from nonconsolidated contributions as well as donations from the Mitsubishi Electric SOCIO-ROOTS Fund. The Fund will collect donations from Mitsubishi Electric employees that the company will then match, effectively doubling the amount donated. The company has begun soliciting donations on its website to enable employees to contribute even while working at home.

Provision of Necessary Materials

(1) Medical masks and other materials

Mitsubishi Electric will provide about 100,000 medical (N95) masks and supplies of disinfectant to medical institutions.

For the full text, please visit: www.MitsubishiElectric.com/news/

View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005360/en/

CONTACT

Customer Inquiries

Corporate Administration Division

Mitsubishi Electric Corporation

Tel: +81-3-3218-9076

www.MitsubishiElectric.com/

Media Inquiries

Takeyoshi Komatsu

Public Relations Division

Mitsubishi Electric Corporation

Tel: +81-3-3218-2346

prd.gnews@nk.MitsubishiElectric.co.jp

www.MitsubishiElectric.com/news/

同じカテゴリーの記事 

  • Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer
  • Fast Company Magazine Awards Xenco Medical with 2024 Innovation by Design Award for the TrabeculeX Continuum
  • PROTEINA Co., Ltd. Announces Breakthrough Research Published in Nature Biomedical Engineering
  • InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 Inhibitor ICP-332 in the U.S.
  • AtriCure已就在中国销售AtriClip®器械获得监管批准